✨
AI Summary
- Reflecting on Janet Woodcock's legacy as US FDA Principal Deputy Commissioner.
- FDA oncology division's stance on confirmatory trials post-accelerated approval.
- Reasons behind the FDA's policy against recording sponsor meetings.